|
Post by orlon on Aug 4, 2017 14:52:48 GMT -5
50million/100million...my point was the only way out is dilution or delusion dilution. Still comes back to sales of AFREZZA. I think my initial comment did stir up some interesting insight though, and some good points/ideas.
|
|
|
Post by orlon on Aug 3, 2017 10:47:10 GMT -5
I don't consider reality to be to doom and gloom. Show me where the money will come from and I'll change my tune, but so far reality seems to be winning.
|
|
|
Post by orlon on Aug 3, 2017 10:11:39 GMT -5
Cash flow problem? No problem. My guess is there will be an announcement of a 100,000,000 new share offering at $1.00/shr with rights. The stock price will be at $1.00/shr on the 7th. This suggestion is not to belittle the new management team as I think they are trying their level best to get the sales up and the name out there, but to state the dire straights they are in financially.
|
|
|
Post by orlon on Aug 2, 2017 18:32:34 GMT -5
I read the research report, watched the video and was heartened by both. Then I looked at the stock price. There is a huge disconnect between here between a game changing drug with life altering potential, and the paultry price of the stock.
|
|
|
Post by orlon on Jul 12, 2017 13:29:02 GMT -5
Pps sure doesn't show any enthusiasm.
|
|
|
Post by orlon on Jul 11, 2017 13:41:05 GMT -5
$10.00/PPS does' mean much after a 1-5 reverse split. Especially when today's pps post split 23 cents.
|
|
|
Post by orlon on Jul 7, 2017 10:27:34 GMT -5
I still own shares but another loss today, possibly below $1.00 next week and the inevitable collapse by the end of the year. I've had this company in my portfolio for years and no longer see any optimism.
|
|
|
Post by orlon on Jul 6, 2017 20:24:38 GMT -5
I don't quite see the same confidence in Mannkind as I did several years ago, or indeed just last year. It appears to me that what has had to be said has been said, what had to be done has been done. I like many others who have lost more than a few dollars in the company, are simply waiting for the inevitable. But claiming 3k/yr loss on my 1040 over the next 10 years (I'll be 83 by then) is a little consolation.
|
|
|
Post by orlon on Jul 5, 2017 15:54:53 GMT -5
Being from NE and visiting my son in Seattle earlier this year, I was checking my bag in at SeaTac for my return flight to Phoenix. The guy checking my bag had a Seahawk jersey with 12 on it. What's a New Englander to say but, ' so you're a Tom Brady fan too eh?' Still no word on where my bag is.
|
|
|
Post by orlon on Jul 3, 2017 11:06:28 GMT -5
Never mind. Just read about the dilution. Also noted statement about RISK. Warrants excercised at $7.50. Maybe in 2030.
|
|
|
Post by orlon on Jul 3, 2017 11:00:22 GMT -5
What's the latest excuse for the PPS drive towards a buck?
|
|
|
Post by orlon on Jun 28, 2017 13:32:52 GMT -5
I like the fact that Greenhill works mergers and acquisitions! I'm pretty sure they are aware of Mannkind's position....now to merge, or put up for sale...that is the question.
|
|
|
Post by orlon on Jun 23, 2017 13:00:42 GMT -5
All this excitement for an early morning gain of .15c/shr...now back to 07c/shr? They have to do better than this after a billion dollar investment over a ten year period with FDA approval over three years ago!
|
|
|
Post by orlon on Jun 20, 2017 10:52:06 GMT -5
Any further dilution would virtually make this stock worthless. I feel we're going around in circles by pushing the ideas of hope further down the timeline and profitability offshore. What started out as a great discovery and benefit to many diabetics has essentially been killed off. Pessimistic viewpoint? Perhaps...but based on reality.
|
|
|
Post by orlon on Jun 15, 2017 11:24:47 GMT -5
I would normally write to my senator John McCain but last time I wrote to him about his proposal to raise Tricare fees on retirees he wrote back several weeks later that we all just had to 'suck it in' if we wanted to pay for new weapon systems.
|
|